RISK STRATIFICATION AS A STRATEGY FOR PHARMACOLOGICAL PROPHYLAXIS OF THROMBOEMBOLISM IN PATIENTS UNDERGOING PLASTIC SURGERY

Abstract

The aim of this study was to investigate and analyze the use of risk stratification as a tool to guide pharmacological prophylaxis of venous thromboembolism (VTE) in patients undergoing plastic surgery. The aim was to understand how different pharmacological strategies can be effectively applied to prevent thromboembolic complications in these contexts. Venous thromboembolism is an important and largely preventable cause of morbidity and mortality after any surgical procedure and affects approximately 1 in 1,000 individuals per year. Risk factors include age, operative time, previous patient conditions and type of surgery. Therefore, it is worth noting that prophylaxis is divided into pharmacological methods, such as enoxaparin and rivaroxaban, and mechanical methods, such as pneumatic compression and physiotherapeutic interventions in the postoperative period. However, there is no consensus on the ideal prophylactic regimen for plastic surgeries. In view of this, the Caprini 2005 RAM score is widely used to stratify patient risk, but its application in aesthetic settings remains limited. It is therefore concluded that VTE prophylaxis in plastic surgery requires individualized risk stratification and further research is needed to standardize prophylactic regimens.